| ABG Management Ltd. | 10% owner | 10.52% | 943,090 | Feb 3, 2026 |
| Williams Eugene | Director | 0.14% | 12,397 | May 20, 2026 |
| Kirwin Patrick D. | Director | 0.11% | 9,788 | Apr 22, 2026 |
| Milbury Max A. | Principal Accounting Officer | 0.09% | 8,409 | May 20, 2026 |
| Warma Neil K | Chief Executive Officer · Director | 0.07% | 6,183 | May 20, 2026 |
| Cashman Neil | Chief Scientific Officer · Director | 0.05% | 4,122 | May 20, 2026 |
| Kaplan Johanne | Chief Development Officer | 0.04% | 3,941 | May 20, 2026 |
| ABG Global Life Science Capital Partners V GP, L.P. | 10% owner | — | — | — |
| ABG Global Life Science Capital Partners V GP Ltd | 10% owner | — | — | — |
| ABG V-SIV IX Ltd | 10% owner | — | — | — |
| ABG V-SIV X Ltd | 10% owner | — | — | — |
| Alex Slanix Paul | Director | — | — | May 20, 2026 |
| Ally Bridge Group Global Life Science Capital Partners V, L.P. | 10% owner | — | — | — |
| Ally Bridge Group (NY) LLC | 10% owner | — | — | — |
| Ally Bridge MedAlpha Master Fund L.P. | 10% owner | — | — | — |
| Mandel-Brehm Josh | Director | — | — | May 20, 2026 |
| Shafmaster Madge K. | Director | — | — | May 20, 2026 |
| WYMAN WILLIAM W | Director | — | — | May 20, 2026 |
| Yu Fan | 10% owner | — | — | — |